Skip to main content

Horizon Plans to Expand in Cambridge

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Horizon Discovery plans to double the size of its office and lab space in Cambridge and it will hire additional staff members, the company said today.

The company is currently seeking to hire up to 10 new staff members for its UK headquarters, which is located at IQ Cambridge, formerly called Cambridge Research Park, Horizon Chairman Darrin Disley said in a statement. The firm expects to have 28 employees at its Cambridge headquarters by the end of this year.

The company also has a staff of six at its facility in Torino, Italy.

The new staff and expanded facilities will support expansion into the companion diagnostics and bio-production markets, Disley added.

Horizon is developing and marketing in vitro discovery and diagnostic tools that can be used to develop and improve cancer drugs, and it is validating and standardizing genetic companion diagnostic tools for cancer. It offers the Genesis gene-targeting platform, and it has a portfolio of genetically defined X-Man human cancer models.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.